Dutasteride plus Tamsulosin fixed-dose combination first-line therapy versus Tamsulosin Monotherapy in the treatment of benign prostatic hyperplasia: a budget impact analysis in the Greek healthcare setting-Reference-Cited by-同舟云学术

Dutasteride plus Tamsulosin fixed-dose combination first-line therapy versus Tamsulosin Monotherapy in the treatment of benign prostatic hyperplasia: a budget impact analysis in the Greek healthcare setting

Published:2014-09-26 Issue:1 Volume:14 Page:
ISSN:1471-2490
Container-title:BMC Urology
language:en
Short-container-title:BMC Urol

Author:

Geitona Maria,Karabela Pinelopi,Katsoulis Ioannis A,Kousoulakou Hara,Lyberopoulou Eleni,Bitros Eleftherios,Xaplanteris Loukas,Papanicolaou Sotiria

Publisher

Springer Science and Business Media LLC

Subject

Urology,Reproductive Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/1471-2490-14-78.pdf

Reference31 articles.

1. Kirby R, McConnel JD, Fitzpatrick JM, Roehrborn CG, Boyle P: Textbook of Benign Prostatic Hyperplasia. 2004, Oxon, UK: CRC Press, 2

2. de la Rosette J, Alivizatos G, Madersbacher S, Sanz CR, Nordling J, Emberton M, Gravas S, Michel MC, Oekle M: Guidelines on benign prostatic hyperplasia. Eur Assoc Urol. 2006, Retrieved fromhttp://www.uroweb.org/fileadmin/user_upload/Guidelines/11%20BPH.pdf on May 19, 2014,

3. Lepor H: Managing and preventing acute urinary retention. Rev Urol. 2005, 7 (Suppl 8): S26-S33.

4. Gravas S, de la Rosette JJ: Investigational therapies targeted to the treatment of benign prostatic hyperplasia. Expert Opin Investig Drugs. 2013, 22 (3): 357-368.

5. Roehrborn CG, Boyle P, Nickel JC, Hoefner K, Andriole G: Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia. Urology. 2002, 60 (3): 434-441.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medical Aspects of the Treatment of LUTS/BPH: Combination Therapies;Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia;2018

2. A cost effective analysis of fixed-dose combination of dutasteride and tamsulosin compared with dutasteride monotherapy for benign prostatic hyperplasia in Nigeria: a middle income perspective; using an interactive Markov model;BMC Cancer;2016-07-07

3. Fixed-dose combination therapy with dutasteride and tamsulosin in the management of benign prostatic hyperplasia;Therapeutic Advances in Urology;2015-10-08